DURATION OF SYMPTOMS, CLINICAL STAGING AND SURVIVAL IN CANCER OF CERTAIN SITES
1956

Duration of Symptoms and Survival in Cancer

Sample size: 60000 publication Evidence: moderate

Author Information

Author(s): A. McKenzie

Primary Institution: General Register Office, Somerset House, London

Hypothesis

How do the duration of symptoms and clinical staging affect survival rates in cancer patients?

Conclusion

The study found that the length of symptomatic history is often not correlated with the stage of cancer at diagnosis, and survival rates are more closely related to the stage of the disease.

Supporting Evidence

  • Patients with longer symptomatic histories often have better survival rates when the cancer is still localized.
  • Advanced cancers with distant metastases are frequently associated with shorter durations of symptoms.
  • Survival rates vary significantly by cancer site and the length of symptomatic history.

Takeaway

This study looked at how long people had symptoms before being diagnosed with cancer and how that affected their chances of surviving. It found that having symptoms for a long time doesn't always mean the cancer is less serious.

Methodology

Analysis of cancer patient records collected by the National Cancer Registration Scheme from 1945 to 1949.

Limitations

The study only includes data from specific cancer sites and may not represent all cancer types.

Participant Demographics

Data collected from cancer patients registered between 1945 and 1949, including both males and females.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication